Barrett's Esophagus Patient Registry



Status:Recruiting
Conditions:Cancer, Gastroesophageal Reflux Disease , Gastrointestinal
Therapuetic Areas:Gastroenterology, Oncology
Healthy:No
Age Range:18 - Any
Updated:4/2/2016
Start Date:January 2011
End Date:December 2021
Contact:Katherine Perzan, BA
Email:kperzan@partners.org
Phone:617-726-1431

Use our guide to learn which trials are right for you!

The ultimate goal of the Barrett's Esophagus Patient Registry is to help develop more
effective targeted screening strategies and treatment options for Barrett's esophagus and
esophageal adenocarcinoma (EAC). We plan to do by developing a registry that will serve as a
platform. Examples of analyses could include identifying genetic determinants and biomarkers
that predict BE, progression of BE to EAC, as well as the response to therapies.


Inclusion Criteria:

- Barrett's (BE): Patients who have Barrett's esophagus (all stages: Barrett's
metaplasia, low-grade dysplasia, high-grade dysplasia) based upon standard endoscopic
and histologic criteria.

- Adenocarcinoma (EAC): Patients who have esophageal adenocarcinoma.

- The control cohort will include patients ages 18 and older with no prior history of
BE and EAC. These may include patients who are being seen or have been previously
seen at MGH GI Associates for conditions including gastroesophageal reflux disease,
peptic esophagitis, eosinophilic esophagitis, esophageal motility disorders such as
achalasia and nutcracker esophagus.

Exclusion Criteria:

- Inability or unwillingness to provide blood samples.

- History of known bleeding disorders.

- Currently awaiting organ transplantation.

- Having an acute or severe chronic illness such as congestive heart failure or any
other condition that would prohibit performing the endoscopy.
We found this trial at
1
site
185 Cambridge Street
Boston, Massachusetts 02114
617-724-5200
?
mi
from
Boston, MA
Click here to add this to my saved trials